Genus PLC (LSE:GNS) - Share price


Stock Report

Genus PLC GNS

Last Price
GBX5,355.00

Day Change
-10.00|-0.19%

As of 23/07/2021
18:29:58 BST | GBX
Minimum 15 Minutes Delay.

Last Close5,365.00p
Day Range5,220.00 - 5,405.00
Mkt Cap3.52Bil
52-Wk Range3,289.44 - 5,515.00
Yield %0.56
ISINGB0002074580
Volume55,249
P/E72.99
P/S0.06
P/CF0.53

Share Price

Total Returns 23/07/2021

 Chg (%)  
More ...
Genus PLC22.71 
FTSE 100 TR GBP0.99
 
Financials
201820192020
More ...
Income Statement
Turnover470.30488.50551.40
Operating Profit14.1030.5066.80
Net Profit41.606.7040.90
Reported EPS68.7011.9061.90
Balance Sheet
Current Assets195.20209.00223.60
Non Current Assets593.80594.40644.90
Total Assets789.20803.60868.70
Current Liabilities125.30104.20130.20
Total Liabilities---
Total Equity419.10487.10507.80
Cash Flow
Operating Cash Flow54.8045.9079.30
Net Change in Cash3.300.9012.00

Regulatory News

DateAuthor Headline
19/11/2018David Brenchley Baillie Gifford: 3 UK Stock Picks for Growth
After winning the mandate from Schroders, Milena Mileva tells us which stocks she has been buying for the Baillie Gifford UK Growth Trust this year
Director Dealings
TradedActionNotifierPriceAmountValue
More ...
10/05/2021PurchaseMr. Stephen Wilson5,010.002100.00
08/04/2021PurchaseMr. Stephen Wilson5,060.003152.00
01/04/2021PurchaseMr. Stephen Wilson4,891.04149.00
31/03/2021PurchaseMr. Iain George Thomas Ferguson CBE4,799.7250023,999.00

Company Profile

Genus PLC is a biotechnology company that develops animal genetics for agricultural purposes. The company breeds and distributes the genes of pigs and bulls, scientifically selecting livestock whose offspring are designed to increase the profitability of its customers. The company generates most of its revenue from its porcine exposure, followed by its bovine exposure. In the porcine market, Genus sells boars and sows that produce offspring with desirable characteristics, such as feed-efficient growth or leaner meat. In the dairy and beef markets, the company's primary product is bull semen, which is delivered through artificial insemination to improve its customers' herds and their efficiency. Genus also offers embryos through its subsidiary IVB.

Sector

Biotechnology

Index

FTSE 250 , FTSE 350 , FTSE All Share , FTSE techMARK Focus , FTSE techMARK All Share

Next Event 08/09/2021

Final Results
Ratios
Comp
More ...
PER (E)67.39
Div Yld (E)0.60
PEG (E)0.00
ROCE7.64
Op Mrgn0.12
EPS Grwth1.49
Dividends
PreviousLatest
More ...
Record Date20/11/2005/03/21
Ex-Div19/11/2004/03/21
Paid11/12/2001/04/21
Amnt19.7010.30
Directors
More ...
Executive Director, Chief Executive OfficerMr. Stephen Wilson
Non-Executive Director, Senior Independent Non-Executive DirectorMs. Lesley Mary Samuel Knox
Non-Executive Director, ChairmanMr. Iain George Thomas Ferguson CBE
Group General Counsel & Company SecretaryMr. Daniel William David Hartley
Non-Executive DirectorMr. Lykele van der Broek
Executive Director, Chief Financial OfficerMs. Alison Henriksen
AJ Bell Management Limited (company number 03948391), AJ Bell Securities Limited (company number 02723420) and AJ Bell Asset Management Limited (company number 09742568) are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. See website for full details. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.
© Copyright 2021 Morningstar. All rights reserved.